@article{773a2d6cd3a44a57a5e3ee29aeac5046,
title = "Allosteric inhibition of hypoxia inducible factor-2 with small molecules",
abstract = "Hypoxia inducible factors (HIFs) are heterodimeric transcription factors induced in many cancers where they frequently promote the expression of protumorigenic pathways. Though transcription factors are typically considered 'undruggable', the PAS-B domain of the HIF-2α subunit contains a large cavity within its hydrophobic core that offers a unique foothold for small-molecule regulation. Here we identify artificial ligands that bind within this pocket and characterize the resulting structural and functional changes caused by binding. Notably, these ligands antagonize HIF-2 heterodimerization and DNA-binding activity in vitro and in cultured cells, reducing HIF-2 target gene expression. Despite the high sequence identity between HIF-2α and HIF-1α, these ligands are highly selective and do not affect HIF-1 function. These chemical tools establish the molecular basis for selective regulation of HIF-2, providing potential therapeutic opportunities to intervene in HIF-2-driven tumors, such as renal cell carcinomas.",
author = "Scheuermann, {Thomas H.} and Qiming Li and Ma, {He Wen} and Jason Key and Lei Zhang and Rui Chen and Garcia, {Joseph A.} and Jacinth Naidoo and Jamie Longgood and Frantz, {Doug E.} and Tambar, {Uttam K.} and Gardner, {Kevin H.} and Bruick, {Richard K.}",
note = "Funding Information: The authors thank S. Wang and members of the University of Texas Southwestern High-Throughput Screening Core Facility, D. Tomchick, C. Brautigam, J. MacMillan, N. Williams and members of our laboratories for their help. This work was funded by grants from the US National Institutes of Health (P01 CA095471, P30 CA142543) and the Cancer Prevention Research Institute of Texas (RP-100846). R.K.B. is the Michael L. Rosenberg Scholar in Medical Research and was supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; K.H.G. is the Virginia Lazenby O{\textquoteright}Hara Chair in Biochemistry and W.W. Caruth Scholar in Biomedical Research; and U.K.T. is a W.W. Caruth Jr. Scholar in Biomedical Research. J.A.G. was supported by funds provided by the Department of Veterans Affairs. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne National Laboratory is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (grant no. C06 RR 15437-01) from the National Center for Research Resources, US National Institutes of Health.",
year = "2013",
month = apr,
doi = "10.1038/nchembio.1185",
language = "English (US)",
volume = "9",
pages = "271--276",
journal = "Nature chemical biology",
issn = "1552-4450",
publisher = "Nature Publishing Group",
number = "4",
}